Currently, there are limited supplies of the reagents used for HIV-1 Western Blot and HIV-2 EIA testing. In order to conserve the remaining reagent, a controlled process of batch testing was implemented. Therefore, you will likely see additional delays in receiving these supplemental test results.
Read about our plan to mitigate this on the Communications page by clicking this link: Communications
On April 29, 2019, CTS will begin performing Donor-Screen HLA® Class I and II testing on the Str...
As an organization dedicated to the safety of the world’s blood and plasma supply, Creative Testing...
CTS communications distributed on July 6th and July 20th.In working with Grifols on the availability...
The CTS 2020 Annual Laboratory Survey is on its way to your email box. We would appreciate you takin...
On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Ris...
We sincerely hope to see you at this year’s AABB Annual Meeting in San Antonio, TX on October ...